A Single and Multiple Ascending Dose Study of CK-3828136 in Healthy Adult Participants

NCT05662215 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

57

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated early per sponsor decision.

Conditions

Healthy Participants

Interventions

DRUG: CK-3828136
DRUG: Placebo for CK-3828136

Sponsor

Cytokinetics